JAGSNPHARM Jagsonpal Pharmaceuticals Ltd Earnings Reports Announcement 2024 - Q2FY25 Financial Results Jagsonpal Pharmaceuticals reported a 29.2% revenue growth to Rs 74.7 Crores for Q2 FY25 and a net profit increase of 52% to Rs 11.4 Crores, while also approving a stock split from Rs 5 to Rs 2 per share..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Jagsonpal Pharmaceuticals Ltd